ARCHIVES

Variation in Breast Density May Be Strong Risk Factor

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

FDA Committee Agenda Includes M-AMSA, THC, Estramustine, Platinum

May 22, 1981

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

August 26, 2005

DeVita Considers Alternatives to Recommendation Of NCAB On Organ Systems Coordinating Center

June 1, 1984

DCE Concepts Statements

March 11, 1988

In Brief: NCAB To Ponder Organ Systems Program Fate, Cancer Centers Issues, Hear Surveillance Review

January 29, 1988

Trials Suspended At Oklahoma Over Study Of Cancer Vaccine.

July 14, 2000